0.18 % w/v Sodium Chloride and 4 % w/v Glucose Intravenous Infusion BP, Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

0.18 % w/v sodium chloride and 4 % w/v glucose intravenous infusion bp, solution for infusion

b. braun medical limited - glucose; sodium chloride - solution for infusion - 0.18 and 4 percent weight/volume - solutions affecting the electrolyte balance; electrolytes with carbohydrates

PHYSIONEAL 40 GLUCOSE 1.36 % WV Israel - English - Ministry of Health

physioneal 40 glucose 1.36 % wv

baxter healthcare distribution ltd., israel - calcium chloride dihydrate; glucose monohydrate (as anhydrous); lactic acid as sodium; magnesium chloride hexahydrate; sodium bicarbonate; sodium chloride - solution for peritoneal dialysis - sodium chloride 5.38 g/l; magnesium chloride hexahydrate 0.051 g/l; lactic acid as sodium 1.68 g/l; sodium bicarbonate 2.10 g/l; glucose monohydrate (as anhydrous) 13.6 g/l; calcium chloride dihydrate 0.184 g/l - sodium chloride - sodium chloride - physioneal is indicated whenever peritoneal dialysis is employed including:acute and chronic renal failure severe water retention severe electrolyte imbalance drug intoxication with dialysable substances when a more adequate therapeutic alternative is not available. bicarbonate/lactate based physioneal peritoneal dialysis solutions with a physiological ph are particularly indicated in patients in whom solutions based on lactate buffer only with a low ph cause abdominal inflow pain or discomfort.

Sodium Chloride 0.9% w/v and Glucose 5% w/v Solution for Infusion BP Malta - English - Medicines Authority

sodium chloride 0.9% w/v and glucose 5% w/v solution for infusion bp

baxter healthcare limited - glucose, sodium chloride - solution for infusion - glucose 9 gram(s)/litre ; sodium chloride 50 gram(s)/litre - blood substitutes and perfusion solutions

Glucose 5% Sodium Chloride 0.45% New Zealand - English - Medsafe (Medicines Safety Authority)

glucose 5% sodium chloride 0.45%

baxter healthcare ltd - glucose 5%; sodium chloride 0.45% - solution for infusion - active: glucose 5% sodium chloride 0.45% excipient: water for injection - glucose and sodium chloride infusion solution is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of medication delivery where intravenous delivery is appropriate and the medicine is compatible with this solution.

Glucose 2.5% Sodium Chloride 0.45% New Zealand - English - Medsafe (Medicines Safety Authority)

glucose 2.5% sodium chloride 0.45%

baxter healthcare ltd - glucose 2.5%; sodium chloride 0.45% - solution for infusion - active: glucose 2.5% sodium chloride 0.45% - glucose and sodium chloride infusion solution is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of medication delivery where intravenous delivery is appropriate and the medicine is compatible with this solution.

Glucose 4% Sodium Chloride 0.18% New Zealand - English - Medsafe (Medicines Safety Authority)

glucose 4% sodium chloride 0.18%

baxter healthcare ltd - glucose 4%; sodium chloride 0.18% - solution for infusion - active: glucose 4% sodium chloride 0.18% - glucose and sodium chloride infusion solution is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of medication delivery where intravenous delivery is appropriate and the medicine is compatible with this solution.

Glucose 5% Sodium Chloride 0.9% New Zealand - English - Medsafe (Medicines Safety Authority)

glucose 5% sodium chloride 0.9%

baxter healthcare ltd - glucose 5%; sodium chloride 0.9% - solution for infusion - active: glucose 5% sodium chloride 0.9% - glucose and sodium chloride infusion solution is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of medication delivery where intravenous delivery is appropriate and the medicine is compatible with this solution.

GLUCOSE 5% FREEFLEX glucose 12.5 g/250 mL injection bag Australia - English - Department of Health (Therapeutic Goods Administration)

glucose 5% freeflex glucose 12.5 g/250 ml injection bag

fresenius kabi australia pty ltd - glucose, quantity: 12.5 g - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - the solutions are indicated for intravenous fluid therapy designed to correct deficiencies in energy levels. glucose 5% is also used to correct hydration levels. the solutions may also be used as solvents for intravenously administered drugs where compatibility has been established.

GLUCOSE 5% FREEFLEX glucose 5g/100mL injection bag Australia - English - Department of Health (Therapeutic Goods Administration)

glucose 5% freeflex glucose 5g/100ml injection bag

fresenius kabi australia pty ltd - glucose, quantity: 5 g - injection, solution - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - the solutions are indicated for intravenous fluid therapy designed to correct deficiencies in energy levels. glucose 5% is also used to correct hydration levels. the solutions may also be used as solvents for intravenously administered drugs where compatibility has been established.

GLUCOSE 5% FREEFLEX glucose 2.5g/50mL injection bag Australia - English - Department of Health (Therapeutic Goods Administration)

glucose 5% freeflex glucose 2.5g/50ml injection bag

fresenius kabi australia pty ltd - glucose, quantity: 2.5 g - injection, solution - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - the solutions are indicated for intravenous fluid therapy designed to correct deficiencies in energy levels. glucose 5% is also used to correct hydration levels. the solutions may also be used as solvents for intravenously administered drugs where compatibility has been established.